Company News

Hungary — The First EU Member that Approves BIBP’s COVID-19 Vaccine

Hungary — The First EU Member that Approves BIBP’s COVID-19 Vaccine

Date:2021-02-05

Inactivated COVID-19 Vaccine (Vero Cell) of Beijing Institute of Biological Products Müller Cecília, Chief Medical Officer of Hungary, announced at a press conference on January 29 that, Hungary’s drug regulator gave use approval to the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., L...

View More +
BIBP’s COVID-19 Vaccine Approved for Emergency Use in Iraq, Pakistan and Morocco!

BIBP’s COVID-19 Vaccine Approved for Emergency Use in Iraq, Pakistan and Morocco!

Date:2021-01-25

Approved for Emergency Use in Iraq       The Iraqi National Regulatory Authority has approved the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd. (BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (“BIBP’s COVID-19 Vaccine”) for emergency use, as reported by Iraqi media on Ja...

View More +